Paper19656992
A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire.
Mir FA and 2 others. Clin Vaccine Immunol, 2009. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire. Papers, record 19656992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19656992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tuberculosis | Major topic |
| Tuberculosis Vaccines | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antigens, Bacterial | |
| BCG Vaccine | |
| Base Sequence | |
| Cell Line | |
| DNA Primers | |
| DNA, Bacterial | |
| Female | |
| Foot-and-Mouth Disease Virus | |
| Genes | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Molecular Sequence Data | |
| Mycobacterium tuberculosis | |
| Recombinant Proteins | |
| T-Lymphocytes | |
| Vaccines, DNA | |
| Viral Proteins |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8309034 | Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. | JAMA | 1994 | https://conductscience.org/library/papers/8309034 | PubMed |
| 2 | 12055256 | Organ-specific CD4+ T cell response during Listeria monocytogenes infection. | J Immunol | 2002 | https://conductscience.org/library/papers/12055256 | PubMed |
| 3 | 9596772 | Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. | Infect Immun | 1998 | https://conductscience.org/library/papers/9596772 | PubMed |
| 4 | 18725418 | A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. | Infect Immun | 2008 | https://conductscience.org/library/papers/18725418 | PubMed |
| 5 | 10076912 | Immunity to tuberculosis: a delicate balance between protection and pathology. | FEMS Immunol Med Microbiol | 1999 | https://conductscience.org/library/papers/10076912 | PubMed |
| 6 | 10973302 | Is the development of a new tuberculosis vaccine possible? | Nat Med | 2000 | https://conductscience.org/library/papers/10973302 | PubMed |
| 7 | 15834403 | Stable antibody expression at therapeutic levels using the 2A peptide. | Nat Biotechnol | 2005 | https://conductscience.org/library/papers/15834403 | PubMed |
| 8 | 7878014 | Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7878014 | PubMed |
| 9 | 14670350 | Immunology of tuberculosis and implications in vaccine development. | Tuberculosis (Edinb) | 2004 | https://conductscience.org/library/papers/14670350 | PubMed |
| 10 | 15501778 | Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis. | Infect Immun | 2004 | https://conductscience.org/library/papers/15501778 | PubMed |
| 11 | 11981306 | Tuberculosis vaccine development. | Curr Opin Pulm Med | 2002 | https://conductscience.org/library/papers/11981306 | PubMed |
| 12 | 8705859 | Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. | Nat Med | 1996 | https://conductscience.org/library/papers/8705859 | PubMed |
| 13 | 17145953 | Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. | Infect Immun | 2007 | https://conductscience.org/library/papers/17145953 | PubMed |
| 14 | 11905811 | How can immunology contribute to the control of tuberculosis? | Nat Rev Immunol | 2001 | https://conductscience.org/library/papers/11905811 | PubMed |
| 15 | 16959383 | The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. | Vaccine | 2007 | https://conductscience.org/library/papers/16959383 | PubMed |
| 16 | 18598729 | Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. | Vaccine | 2008 | https://conductscience.org/library/papers/18598729 | PubMed |
| 17 | 14991076 | Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. | J Clin Invest | 2004 | https://conductscience.org/library/papers/14991076 | PubMed |
| 18 | 10085007 | Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. | Infect Immun | 1999 | https://conductscience.org/library/papers/10085007 | PubMed |
| 19 | 9529077 | Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. | Infect Immun | 1998 | https://conductscience.org/library/papers/9529077 | PubMed |
| 20 | 12121223 | Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis. | Immunol Cell Biol | 2002 | https://conductscience.org/library/papers/12121223 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42084636 | mRNA vaccine development for tuberculosis: antigen design, immune mechanisms, and translational challenges. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42084636 | PubMed |
| 38096736 | An antibody-free evaluation of an mRNA COVID-19 vaccine. | Biologicals | 2024 | https://conductscience.org/library/papers/38096736 | PubMed |
| 35116175 | Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection. | J Adv Res | 2022 | https://conductscience.org/library/papers/35116175 | PubMed |
| 33445494 | Oral Vaccination of Grass Carp (Ctenopharyngodon idella) with Baculovirus-Expressed Grass Carp Reovirus (GCRV) Proteins Induces Protective Immunity against GCRV Infection. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33445494 | PubMed |
| 33202780 | A Novel Subunit Vaccine Based on Outer Capsid Proteins of Grass Carp Reovirus (GCRV) Provides Protective Immunity against GCRV Infection in Rare Minnow (Gobiocypris rarus). | Pathogens | 2020 | https://conductscience.org/library/papers/33202780 | PubMed |
| 28498840 | A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28498840 | PubMed |
| 28070534 | Design and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis. | Rep Biochem Mol Biol | 2016 | https://conductscience.org/library/papers/28070534 | PubMed |
| 26076321 | Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine. | Hum Vaccin Immunother | 2015 | https://conductscience.org/library/papers/26076321 | PubMed |
| 25961021 | Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25961021 | PubMed |
| 24280763 | A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24280763 | PubMed |
| 22570667 | Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22570667 | PubMed |
| 22216134 | Comparison of IRES and F2A-based locus-specific multicistronic expression in stable mouse lines. | PLoS One | 2011 | https://conductscience.org/library/papers/22216134 | PubMed |
| 22144485 | Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis. | Infect Immun | 2012 | https://conductscience.org/library/papers/22144485 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19656992
GET https://conductscience.org/api/papers/v1/19656992/references?page=2